Daniel Lee

Daniel Lee is an experienced professional who currently holds the position of Chief Executive Officer at Tissue Regenix Group. In the past, Daniel has held various leadership roles in companies such as CellRight Technologies LLC, Scaffold Biologics, Aperion Biologics, Smith & Nephew Endoscopy, OsteoBiologics, Regeneration Technologies, Surgical Dynamics, and U.S. Surgical Corp. Daniel holds a BES in Materials Science & Engineering from The Johns Hopkins University and an MS in Biomedical Engineering from the University of Alabama at Birmingham.